Profil
Scott Moorefield served as the Senior Vice President of Business Development at Silverback Therapeutics, Inc. and as the Chief Business Officer at Boundless Bio, Inc. from 2019 to 2020.
He holds a doctorate degree from North Carolina State University, which he received in 2005, and an undergraduate degree from The University of North Carolina at Chapel Hill, which he received in 1996.
Anciens postes connus de Scott Moorefield
| Sociétés | Poste | Fin |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2022 |
| BOUNDLESS BIO, INC. | Corporate Officer/Principal | 01/06/2020 |
Formation de Scott Moorefield
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| North Carolina State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BOUNDLESS BIO, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
